IL-2/IL-4/IL-7/IL-9/IL-13/IL-15 Receptor Complex Antibodies
Santa Cruz Biotechnology features a diverse variety of IL-2/IL-4/IL-7/IL-9/IL-13/IL-15 Receptor Complex monoclonal antibodies for immunology and cell signaling research. IL-2/IL-4/IL-7/IL-9/IL-13/IL-15 Receptor Complex Antibodies are compatible with multiple experimental techniques, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA).IL-2/IL-4/IL-7/IL-9/IL-13/IL-15 receptor complexes regulate immune responses by influencing T cell proliferation, differentiation, and survival. The receptor complexes are fundamental for the development and function of various immune cells, including T cells and B cells. Research has shown that IL-2/IL-4/IL-7/IL-9/IL-13/IL-15 receptor complexes are involved in numerous diseases, including autoimmune disorders and cancers. Understanding the signaling pathways mediated by IL-2/IL-4/IL-7/IL-9/IL-13/IL-15 receptor complexes is essential for developing targeted therapies and advancing knowledge of immune system dynamics.Santa Cruz Biotechnology monoclonal antibodies enable researchers to explore immune regulation mechanisms and contribute to breakthrough discoveries in immunology and therapeutic development.
SEE ALSO...
Learn more about our ImmunoCruz® Antibody Conjugates and Cruz Marker™ MW Standards Promotional
IL-2/IL-4/IL-7/IL-9/IL-13/IL-15 Receptor Complex Antibodies
| Empty Table Header | Product Name | CATALOG # | ISOTYPE | EPITOPE | APPLICATIONS | Species | Citations | RATING |
|---|---|---|---|---|---|---|---|---|
IL-2R Antibody (A00073.01) | sc-81042 | rat IgG1 | (m) | FCM | m | new | ||
IL-2R Antibody (NYRmIL-2R) | sc-73315 | rat IgG1 | (m) | FCM | m | new | ||
IL-2R Antibody (YNRhIL2R) | sc-73314 | mouse IgG2a | (h) | FCM | h | new | ||
IL-2Rα Antibody (C-9) | sc-393326 | mouse IgG2b κ | 23-49 (m) | WB, IP, IF, ELISA | m, r, h | 2 | ||
IL-2Rα Antibody (BC96) | sc-19628 | mouse IgG1 κ | FL (h) | FCM | h | 1 | ||
IL-2Rα Antibody (C-11) | sc-365511 | mouse IgG2b κ | FL (h) | WB, IP, IF, ELISA | m, r, h | 1 | ||
IL-2Rα Antibody (G-7) | sc-365912 | mouse IgM κ | 23-49 (h) | WB, IP, IF, ELISA | h | new | ||
IL-2Rα Antibody (H-6) | sc-374034 | mouse IgG2a κ | FL (h) | WB, IP, IF, ELISA | h | new | ||
IL-2Rα Antibody (IL2R.1) | sc-57297 | mouse IgG1 | (h) | IF, IHC(P) | h | 1 | ||
IL-2Rβ Antibody (C-2) | sc-166427 | mouse IgG2b κ | 502-533 (h) | WB, IP, IF, IHC(P), ELISA | h | new | ||
IL-2Rβ Antibody (C-10) | sc-393093 | mouse IgG2b κ | 502-522 (m) | WB, IP, IF, ELISA | m, r, h | 1 | ||
IL-2Rβ Antibody (C-6) | sc-393362 | mouse IgG1 κ | 496-523 (m) | WB, IP, IF, ELISA | m, r, h | 1 | ||
IL-2Rβ Antibody (D-12) | sc-376003 | mouse IgG1 κ | 521-551 (h) | WB, IP, IF, ELISA | m, r, h | new | ||
IL-2Rβ Antibody (G-1) | sc-393092 | mouse IgG2a κ | 499-522 (m) | WB, IP, IF, ELISA | m, r, h | 1 | ||
IL-2Rβ Antibody (TM-β1) | sc-19583 | rat IgG2b | FL (m) | IP, IF, IHC(P), FCM | m | new | ||
IL-2Rγ Antibody (A-10) | sc-271060 | mouse IgG2a κ | 342-369 (h) | WB, IP, IF, IHC(P), ELISA | h | 2 | ||
IL-2Rγ Antibody (E-7) | sc-365910 | mouse IgG1 κ | 22-49 (h) | WB, IP, IF, ELISA | h | new | ||
IL-2Rγ Antibody (G-3) | sc-374179 | mouse IgG1 κ | 70-369 (h) | WB, IP, IF, ELISA | h | new | ||
IL-4Rα Antibody (H-4) | sc-28361 | mouse IgG2a κ | 527-825 (h) | WB, IP, IF, IHC(P), ELISA | m, r, h | 15 | ||
IL-4Rα Antibody (E-1) | sc-165974 | mouse IgG1 κ | 511-810 (m) | WB, IP, IF, IHC(P), ELISA | m, r, h | 4 | ||
IL-4Rα Antibody (D-2) | sc-137257 | mouse IgG1 κ | 511-810 (m) | WB, IP, IF, ELISA | m | new | ||
IL-4Rα Antibody (G-9) | sc-137256 | mouse IgG1 κ | 511-810 (m) | WB, IP, IF, ELISA | m | new | ||
IL-7R Antibody (G-11) | sc-514445 | mouse IgG1 κ | 1-215 (h) | WB, IP, IF, ELISA | m, r, h | 4 | ||
IL-9R Antibody (F-3) | sc-515622 | mouse IgG1 κ | 41-270 (h) | WB, IP, IF, ELISA | m, r, h | 2 | ||
IL-9R Antibody (17J-1) | sc-80119 | rat IgG2a | (m) | WB, FCM, ELISA | m | 1 | ||
IL-13Rα1 Antibody (D-2) | sc-398831 | mouse IgG1 κ | 128-427 (h) | WB, IP, IF, ELISA | m, r, h | 4 | ||
IL-13Rα1 Antibody (GM-1C8) | sc-101381 | mouse IgG1 κ | (h) | FCM, ELISA | h | new | ||
IL-13Rα1 Antibody (GM-1E7) | sc-101382 | mouse IgG1 κ | (h) | IF, FCM, ELISA | h | 2 | ||
IL-13Rα2 Antibody (2K8) | sc-134363 | mouse IgG2a κ | 27-127 (h) | WB, IP, ELISA | m, r, h | 7 | ||
IL-13Rα2 Antibody (YY-23Z) | sc-74160 | mouse IgG1 | (h) | WB, IP | h | 2 | ||
IL-13Rα2 Antibody (B-D13) | sc-57267 | mouse IgG1 | (h) | IF, IHC(P), FCM | h | 8 | ||
IL-15Rα Antibody (G-3) | sc-374023 | mouse IgG2a κ | 21-54 (h) | WB, IP, IF, ELISA | m, r, h | 4 | ||
IL-15Rα Antibody (G-7) | sc-271366 | mouse IgG1 κ | 24-130 (h) | WB, IP, IF, ELISA | h | 1 |
IL-2/IL-4/IL-7/IL-9/IL-13/IL-15 Receptor Complex CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | Product Name | CATALOG # | Species | APPLICATIONS | MARKER | Citations | RATING |
|---|---|---|---|---|---|---|---|
IL-2Rα CRISPR/Cas9 KO Plasmid (h) | sc-401262 | h | Gene Knockout | GFP | 0 | ||
IL-2Rα HDR Plasmid (h) | sc-401262-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
IL-2Rα Double Nickase Plasmid (h) | sc-401262-NIC | h | Gene Knockout | Puromycin | 0 | ||
IL-2Rα Double Nickase Plasmid (h2) | sc-401262-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
IL-2Rα CRISPR/Cas9 KO Plasmid (m) | sc-421105 | m | Gene Knockout | GFP | 0 | ||
IL-2Rα HDR Plasmid (m) | sc-421105-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
IL-2Rβ CRISPR/Cas9 KO Plasmid (h) | sc-403250 | h | Gene Knockout | GFP | 0 | ||
IL-2Rβ HDR Plasmid (h) | sc-403250-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
IL-2Rβ Double Nickase Plasmid (h) | sc-403250-NIC | h | Gene Knockout | Puromycin | 0 | ||
IL-2Rβ Double Nickase Plasmid (h2) | sc-403250-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
IL-2Rγ CRISPR/Cas9 KO Plasmid (h) | sc-401876 | h | Gene Knockout | GFP | 0 | ||
IL-2Rγ HDR Plasmid (h) | sc-401876-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
IL-2Rγ Double Nickase Plasmid (h) | sc-401876-NIC | h | Gene Knockout | Puromycin | 0 | ||
IL-2Rγ Double Nickase Plasmid (h2) | sc-401876-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
IL-2Rγ CRISPR/Cas9 KO Plasmid (m) | sc-421107 | m | Gene Knockout | GFP | 0 | ||
IL-2Rγ HDR Plasmid (m) | sc-421107-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
IL-4Rα CRISPR/Cas9 KO Plasmid (m) | sc-421111 | m | Gene Knockout | GFP | 1 | ||
IL-4Rα HDR Plasmid (m) | sc-421111-HDR | m | Homology Directed Repair | Puromycin | 1 | ||
IL-4Rα Double Nickase Plasmid (m) | sc-421111-NIC | m | Gene Knockout | Puromycin | 1 | ||
IL-4Rα Double Nickase Plasmid (m2) | sc-421111-NIC-2 | m | Gene Knockout | Puromycin | 1 | ||
IL-7R Double Nickase Plasmid (h) | sc-401536-NIC | h | Gene Knockout | Puromycin | 0 | ||
IL-7R Double Nickase Plasmid (h2) | sc-401536-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
IL-15Rα Double Nickase Plasmid (h) | sc-416909-NIC | h | Gene Knockout | Puromycin | 0 | ||
IL-15Rα Double Nickase Plasmid (h2) | sc-416909-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
IL-15Rα CRISPR/Cas9 KO Plasmid (m) | sc-421090 | m | Gene Knockout | GFP | 0 | ||
IL-13Rα1 Double Nickase Plasmid (h) | sc-405042-NIC | h | Gene Knockout | Puromycin | 0 | ||
IL-13Rα1 Double Nickase Plasmid (h2) | sc-405042-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
IL-13Rα2 CRISPR/Cas9 KO Plasmid (h) | sc-402525 | h | Gene Knockout | GFP | 0 | ||
IL-13Rα2 Double Nickase Plasmid (h) | sc-402525-NIC | h | Gene Knockout | Puromycin | 0 | ||
IL-13Rα2 Double Nickase Plasmid (h2) | sc-402525-NIC-2 | h | Gene Knockout | Puromycin | 0 |
IL-2/IL-4/IL-7/IL-9/IL-13/IL-15 Receptor Complex CRISPR Activation Products
| Empty Table Header | Product Name | CATALOG # | Species | APPLICATIONS | MARKER | Citations | RATING |
|---|---|---|---|---|---|---|---|
IL-2Rα CRISPR Activation Plasmid (h) | sc-401262-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-2Rβ CRISPR Activation Plasmid (h) | sc-403250-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-2Rβ CRISPR Activation Plasmid (h2) | sc-403250-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-2Rγ CRISPR Activation Plasmid (h) | sc-401876-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-4Rα CRISPR Activation Plasmid (h) | sc-418209-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-4Rα Lentiviral Activation Particles (h) | sc-418209-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-7R CRISPR Activation Plasmid (h) | sc-401536-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-15Rα CRISPR Activation Plasmid (m) | sc-421090-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-15Rα CRISPR Activation Plasmid (m2) | sc-421090-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-15Rα Lentiviral Activation Particles (m2) | sc-421090-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-13Rα1 CRISPR Activation Plasmid (h) | sc-405042-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-13Rα2 CRISPR Activation Plasmid (h) | sc-402525-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-13Rα2 CRISPR Activation Plasmid (h2) | sc-402525-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
IL-13Rα2 Lentiviral Activation Particles (h2) | sc-402525-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 |
IL-2/IL-4/IL-7/IL-9/IL-13/IL-15 Receptor Complex siRNA, shRNA Plasmid and shRNA Lentiviral Particle Gene Silencers
| Empty Table Header | Product Name | CATALOG # | Species | APPLICATIONS | MARKER | Citations | RATING |
|---|---|---|---|---|---|---|---|
IL-2Rα siRNA (h) | sc-29367 | h | Gene Silencing | N/A | 0 | ||
IL-2Rα shRNA Plasmid (h) | sc-29367-SH | h | Gene Silencing | Puromycin | 0 | ||
IL-2Rα shRNA (h) Lentiviral Particles | sc-29367-V | h | Gene Silencing | Puromycin | 0 | ||
IL-2Rα siRNA (m) | sc-35657 | m | Gene Silencing | N/A | 0 | ||
IL-2Rα shRNA Plasmid (m) | sc-35657-SH | m | Gene Silencing | Puromycin | 0 | ||
IL-2Rα shRNA (m) Lentiviral Particles | sc-35657-V | m | Gene Silencing | Puromycin | 0 | ||
IL-2Rβ siRNA (h) | sc-35654 | h | Gene Silencing | N/A | 0 | ||
IL-2Rβ shRNA Plasmid (h) | sc-35654-SH | h | Gene Silencing | Puromycin | 0 | ||
IL-2Rβ shRNA (h) Lentiviral Particles | sc-35654-V | h | Gene Silencing | Puromycin | 0 | ||
IL-2Rβ siRNA (m) | sc-35655 | m | Gene Silencing | N/A | 0 | ||
IL-2Rβ shRNA Plasmid (m) | sc-35655-SH | m | Gene Silencing | Puromycin | 0 | ||
IL-2Rβ shRNA (m) Lentiviral Particles | sc-35655-V | m | Gene Silencing | Puromycin | 0 | ||
IL-2Rγ siRNA (h) | sc-35653 | h | Gene Silencing | N/A | 0 | ||
IL-2Rγ shRNA Plasmid (h) | sc-35653-SH | h | Gene Silencing | Puromycin | 0 | ||
IL-2Rγ shRNA (h) Lentiviral Particles | sc-35653-V | h | Gene Silencing | Puromycin | 0 | ||
IL-2Rγ siRNA (m) | sc-35656 | m | Gene Silencing | N/A | 0 | ||
IL-2Rγ shRNA Plasmid (m) | sc-35656-SH | m | Gene Silencing | Puromycin | 0 | ||
IL-2Rγ shRNA (m) Lentiviral Particles | sc-35656-V | m | Gene Silencing | Puromycin | 0 | ||
IL-4Rα siRNA (h) | sc-35661 | h | Gene Silencing | N/A | 1 | ||
IL-4Rα shRNA Plasmid (h) | sc-35661-SH | h | Gene Silencing | Puromycin | 1 | ||
IL-4Rα shRNA (h) Lentiviral Particles | sc-35661-V | h | Gene Silencing | Puromycin | 1 | ||
IL-4Rα siRNA (m) | sc-35662 | m | Gene Silencing | N/A | 3 | ||
IL-4Rα shRNA Plasmid (m) | sc-35662-SH | m | Gene Silencing | Puromycin | 3 | ||
IL-4Rα shRNA (m) Lentiviral Particles | sc-35662-V | m | Gene Silencing | Puromycin | 3 | ||
IL-7R siRNA (h) | sc-35664 | h | Gene Silencing | N/A | 4 | ||
IL-7R shRNA Plasmid (h) | sc-35664-SH | h | Gene Silencing | Puromycin | 4 | ||
IL-7R shRNA (h) Lentiviral Particles | sc-35664-V | h | Gene Silencing | Puromycin | 4 | ||
IL-7R siRNA (m) | sc-35665 | m | Gene Silencing | N/A | 0 | ||
IL-7R shRNA Plasmid (m) | sc-35665-SH | m | Gene Silencing | Puromycin | 0 | ||
IL-7R shRNA (m) Lentiviral Particles | sc-35665-V | m | Gene Silencing | Puromycin | 0 | ||
IL-9R siRNA (h) | sc-40049 | h | Gene Silencing | N/A | 0 | ||
IL-9R shRNA Plasmid (h) | sc-40049-SH | h | Gene Silencing | Puromycin | 0 | ||
IL-9R shRNA (h) Lentiviral Particles | sc-40049-V | h | Gene Silencing | Puromycin | 0 | ||
IL-9R siRNA (m) | sc-40050 | m | Gene Silencing | N/A | 0 | ||
IL-9R shRNA Plasmid (m) | sc-40050-SH | m | Gene Silencing | Puromycin | 0 | ||
IL-9R shRNA (m) Lentiviral Particles | sc-40050-V | m | Gene Silencing | Puromycin | 0 | ||
IL-15Rα siRNA (h) | sc-40051 | h | Gene Silencing | N/A | 1 | ||
IL-15Rα shRNA Plasmid (h) | sc-40051-SH | h | Gene Silencing | Puromycin | 1 | ||
IL-15Rα shRNA (h) Lentiviral Particles | sc-40051-V | h | Gene Silencing | Puromycin | 1 | ||
IL-15Rα siRNA (m) | sc-40052 | m | Gene Silencing | N/A | 1 | ||
IL-15Rα shRNA Plasmid (m) | sc-40052-SH | m | Gene Silencing | Puromycin | 1 | ||
IL-15Rα shRNA (m) Lentiviral Particles | sc-40052-V | m | Gene Silencing | Puromycin | 1 | ||
IL-13Rα1 siRNA (h) | sc-63337 | h | Gene Silencing | N/A | 1 | ||
IL-13Rα1 shRNA Plasmid (h) | sc-63337-SH | h | Gene Silencing | Puromycin | 1 | ||
IL-13Rα1 shRNA (h) Lentiviral Particles | sc-63337-V | h | Gene Silencing | Puromycin | 1 | ||
IL-13Rα1 siRNA (m) | sc-63338 | m | Gene Silencing | N/A | 0 | ||
IL-13Rα1 shRNA Plasmid (m) | sc-63338-SH | m | Gene Silencing | Puromycin | 0 | ||
IL-13Rα1 shRNA (m) Lentiviral Particles | sc-63338-V | m | Gene Silencing | Puromycin | 0 | ||
IL-13Rα2 siRNA (h) | sc-63339 | h | Gene Silencing | N/A | 2 | ||
IL-13Rα2 shRNA Plasmid (h) | sc-63339-SH | h | Gene Silencing | Puromycin | 2 | ||
IL-13Rα2 shRNA (h) Lentiviral Particles | sc-63339-V | h | Gene Silencing | Puromycin | 2 | ||
IL-13Rα2 siRNA (m) | sc-63340 | m | Gene Silencing | N/A | 0 | ||
IL-13Rα2 shRNA Plasmid (m) | sc-63340-SH | m | Gene Silencing | Puromycin | 0 | ||
IL-13Rα2 shRNA (m) Lentiviral Particles | sc-63340-V | m | Gene Silencing | Puromycin | 0 |